FIGURE

Fig. 6

ID
ZDB-FIG-221114-20
Publication
Harms et al., 2021 - An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation
Other Figures
All Figure Page
Back to All Figure Page
Fig. 6

Effect of EPI-X4 derivatives and AMD3100 on CXCL12-evoked Ca2+ mobilization and ERK and AKT signaling. (A) Inhibition of CXCL12-induced calcium release. BCR-ABL expressing murine pro/pre B cells were loaded with Indo-1 AM and incubated with inhibitors for 10 min. Baseline fluorescence signal was recorded for 30 s and calcium flux induced by stimulation with 100 ng/mL mCXCL12 (black arrow). Signal was recorded for additional 260 s. (B) Areas under the curves (AUC) was calculated after baseline subtraction. Data were represented as mean ± SEM (n = 3). (C) and (D) Inhibition of CXCL12-induced ERK and AKT phosphorylation. SupT1 cells were preincubated with indicated concentrations of compounds for 15 min in starvation medium and afterwards stimulated with 100 ng/mL CXCL12 for 2 min. Cells were then permeabilized and stained for phosphorylated ERK (C) or phosphorylated AKT (D) and analyzed in flow cytometry. Data were represented as mean ± SEM (n = 3). IC50 values were determined by non-linear regression. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001; ∗∗∗∗P > 0.0001; ns = not significant (one-way ANOVA in comparison to PBS control).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Acta Pharm Sin B